2023
Data‐driven classification of health status of older adults with diabetes: The diabetes and aging study
Huang E, Liu J, Lipska K, Grant R, Laiteerapong N, Moffet H, Schumm L, Karter A. Data‐driven classification of health status of older adults with diabetes: The diabetes and aging study. Journal Of The American Geriatrics Society 2023, 71: 2120-2130. PMID: 36883732, PMCID: PMC10363208, DOI: 10.1111/jgs.18310.Peer-Reviewed Original ResearchConceptsOlder adultsBaseline comorbiditiesCardiovascular eventsHigh prevalenceClass 3Integrated healthcare delivery systemRisk of complicationsType 2 diabetesClass 1Population health managementRace-adjusted ratesClass 2Healthcare delivery systemIncident complicationsCause mortalityMicrovascular eventsCohort studyComplication ratePrevalent comorbiditiesComorbid conditionsFuture complicationsHypoglycemic eventsDiabetes careCardiovascular conditionsLow prevalence
2019
379-P: Changes in Diabetes Management after a Hospital Visit for Severe Hypoglycemia
VIJAYAKUMAR P, LIU S, KAHN P, MCCOY R, KARTER A, LIPSKA K. 379-P: Changes in Diabetes Management after a Hospital Visit for Severe Hypoglycemia. Diabetes 2019, 68 DOI: 10.2337/db19-379-p.Peer-Reviewed Original ResearchSevere hypoglycemic eventsType 2 diabetesDiabetes managementSevere hypoglycemiaHypoglycemic eventsNational InstituteGlucose-lowering medicationsGlucose-lowering therapyProportion of patientsThird of patientsEmergency department visitsPhysician office visitsContinuous glucose monitor useBaseline HbA1cED visitsDepartment visitsHospital admissionKidney diseaseOffice visitsMean ageHospital visitsClinical guidelinesMedication fillsHypoglycemiaDiabetes
2018
Does Initiation of Basal Insulin Analogs in Patients with Type 2 Diabetes Mellitus Confer Advantages over Neutral Protamine Hagedorn (NPH) for Severe Hypoglycemia and Glycemic Control?
LIPSKA K, PARKER M, MOFFET H, HUANG E, KARTER A. Does Initiation of Basal Insulin Analogs in Patients with Type 2 Diabetes Mellitus Confer Advantages over Neutral Protamine Hagedorn (NPH) for Severe Hypoglycemia and Glycemic Control? Diabetes 2018, 67 DOI: 10.2337/db18-1311-p.Peer-Reviewed Original ResearchNeutral protamine HagedornType 2 diabetesReal-world clinical practiceSevere hypoglycemiaGlycemic controlInsulin analoguesClinical practiceKaiser Permanente Northern CaliforniaDiabetes medication useInsulin analogue useBasal insulin analoguesClinical trial populationsType of insulinHealth plan coverageHazard ratioInsulin initiationNPH insulinPatient characteristicsBasal insulinHemoglobin A1cMedication useSulfonylurea treatmentTrial populationHypoglycemic eventsNocturnal hypoglycemia